BioDesign AI Suite

Intelligent Biomolecule Design Platform

8 modules active

From Sequence to Candidate Drug

Shift from screening to intelligent design. Leverage AI to discover, optimize, and validate large molecule therapeutics including antibodies, peptides, and novel proteins.

Design Tools

Protein Editor

3D structure visualization and editing with point mutations, loop grafting, and humanization

Antibody Designer

AI-powered de novo antibody generation with high affinity and specificity

De Novo Protein Designer

Premium

Generate novel proteins with specific functions or structural scaffolds

Peptide Designer

Design therapeutic peptides with high stability and cell permeability

Structure2Sequence

Premium

Reverse design sequences that fold into desired functional structures

Prediction & Analysis

PPI Predictor

Predict protein-protein interactions, binding affinity, and binding free energy

Immunogenicity Predictor

Critical! Predict immune response risk and suggest modifications

Quality Assessment

Developability Profiler

Analyze solubility, viscosity, aggregation, and chemical stability

Data Management

Biological Datasets

Manage training data: antibody libraries, structure databases, PPI data

Example Workflow: Cancer Target X Antibody

1

Input Target Structure

Upload PDB ID for cancer target X in Antibody Designer

2

AI Generation

Generate hundreds of candidate antibody sequences with specified parameters

3

Virtual Screening

PPI Predictor ranks by affinity → Protein Editor for refinement

4

Risk Assessment

Filter candidates using Immunogenicity Predictor and Developability Profiler

5

Structure Validation

Verify 3D structures and binding with Sequence2Structure (AlphaFold2)

10k+
Protein Structures
98.5%
Prediction Accuracy
50x
Faster Than Traditional
500+
Validated Candidates